Entwicklung eines Prototyps für die Point-of-Care-Diagnostik von Blutammoniak
Beschreibung
Hyperammonemia and associated neurological manifestations (hepatic encephalopathy) lead to coma and death and incur high costs. It affects 30-45% of cirrhotic patients. A novel portable point of care device based on pH-gradient polymersomes for daily monitoring of ammonia will alleviate the burdens.
Eckdaten
Projektleitung
Stellv. Projektleitung
Projektteam
Projektpartner
Versantis AG
Projektstatus
abgeschlossen, 04/2022 - 01/2025
Institut/Zentrum
Institute of Computational Physics (ICP)
Drittmittelgeber
Innosuisse
Projektvolumen
567'592 CHF
